JP2021518432A5 - - Google Patents

Info

Publication number
JP2021518432A5
JP2021518432A5 JP2020573089A JP2020573089A JP2021518432A5 JP 2021518432 A5 JP2021518432 A5 JP 2021518432A5 JP 2020573089 A JP2020573089 A JP 2020573089A JP 2020573089 A JP2020573089 A JP 2020573089A JP 2021518432 A5 JP2021518432 A5 JP 2021518432A5
Authority
JP
Japan
Prior art keywords
gene expression
response signature
subject
tnf
expression response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020573089A
Other languages
English (en)
Japanese (ja)
Other versions
JP7496324B2 (ja
JP2021518432A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/022588 external-priority patent/WO2019178546A1/en
Publication of JP2021518432A publication Critical patent/JP2021518432A/ja
Publication of JP2021518432A5 publication Critical patent/JP2021518432A5/ja
Application granted granted Critical
Publication of JP7496324B2 publication Critical patent/JP7496324B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020573089A 2018-03-16 2019-03-15 抗ｔｎｆ療法に対する応答性を予測するための方法及びシステム Active JP7496324B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862644070P 2018-03-16 2018-03-16
US62/644,070 2018-03-16
PCT/US2019/022588 WO2019178546A1 (en) 2018-03-16 2019-03-15 Methods and systems for predicting response to anti-tnf therapies

Publications (3)

Publication Number Publication Date
JP2021518432A JP2021518432A (ja) 2021-08-02
JP2021518432A5 true JP2021518432A5 (enExample) 2022-02-14
JP7496324B2 JP7496324B2 (ja) 2024-06-06

Family

ID=67907331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020573089A Active JP7496324B2 (ja) 2018-03-16 2019-03-15 抗ｔｎｆ療法に対する応答性を予測するための方法及びシステム

Country Status (4)

Country Link
US (3) US11198727B2 (enExample)
EP (1) EP3765634A4 (enExample)
JP (1) JP7496324B2 (enExample)
WO (1) WO2019178546A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019178546A1 (en) 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
US12548678B2 (en) 2020-05-14 2026-02-10 Ampel Biosolutions, Llc Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupus
JP2022541125A (ja) 2019-06-27 2022-09-22 サイファー メディシン コーポレーション 患者を層別化するための分類子の開発
WO2022051245A2 (en) * 2020-09-01 2022-03-10 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
KR20230165746A (ko) 2020-11-30 2023-12-05 민데라 코포레이션 마이크로니들 디바이스 및 방법, 및 피부 병태 어세이
EP4015651A1 (en) * 2020-12-17 2022-06-22 Koninklijke Philips N.V. Treatment prediction and effectiveness of anti-tnf alpha treatment in ibd patients
EP4308732A4 (en) * 2021-03-19 2025-02-26 Scipher Medicine Corporation METHODS FOR CLASSIFICATION AND TREATMENT OF PATIENTS
WO2022240875A1 (en) 2021-05-13 2022-11-17 Scipher Medicine Corporation Assessing responsiveness to therapy
WO2022271717A1 (en) * 2021-06-22 2022-12-29 Scipher Medicine Corporation Methods and systems for personalized therapies
EP4359567A4 (en) * 2021-06-22 2025-06-11 Scipher Medicine Corporation METHODS AND SYSTEMS FOR THERAPY MONITORING AND EXPERIMENTAL CONDUCT
EP4720125A1 (en) 2023-05-30 2026-04-08 Paragon Therapeutics, Inc. Alpha4beta7 integrin antibody compositions and methods of use
EP4762093A1 (en) 2023-08-14 2026-06-24 Paragon Therapeutics, Inc. Alpha 4 beta 7 integrin binding proteins and methods of use
GB202410224D0 (en) * 2024-07-12 2024-08-28 Univ London Queen Mary Method for treating rhematoid arthritis

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040120952A1 (en) * 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
EP2161348A1 (en) 2005-09-27 2010-03-10 Source MDX Gene expression profiling for identification monitoring and treatment of rheumatoid arthritis
TW201337266A (zh) 2005-11-01 2013-09-16 Abbott Biotech Ltd 利用生物標記診斷關節黏連脊椎炎之方法及組合物
US20080026485A1 (en) 2006-04-18 2008-01-31 Wolfgang Hueber Antibody profiling for determination of patient responsiveness
EP2165194A4 (en) 2007-05-31 2010-09-08 Abbott Lab BIOMARKERS FOR PREDICTING RESPONSABILITY TO TNF ALPHA INHIBITORS IN AUTOIMMUNE DISEASES
SG182183A1 (en) * 2007-06-08 2012-07-30 Biogen Idec Inc Biomarkers for predicting anti-tnf responsiveness or non-responsiveness
US7863021B2 (en) 2007-09-05 2011-01-04 Celera Corporation Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
WO2009102957A2 (en) 2008-02-14 2009-08-20 The Johns Hopkins University Methods to connect gene set expression profiles to drug sensitivity
WO2009117791A2 (en) * 2008-03-28 2009-10-01 Katholieke Universiteit Leuven Mucosal gene signatures
JP2012500993A (ja) * 2008-08-25 2012-01-12 ヤンセン バイオテツク，インコーポレーテツド 潰瘍性大腸炎及び関連した疾患における抗ｔｎｆ処置のためのバイオマーカー
US20110191087A1 (en) 2008-09-03 2011-08-04 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Computer implemented model of biological networks
CA2737485A1 (en) 2008-10-10 2010-04-15 Mount Sinai Hospital Methods for classifying samples based on network modularity
JP5996429B2 (ja) 2009-09-03 2016-09-21 ジェネンテック， インコーポレイテッド 関節リウマチの治療、診断及びモニターするための方法
CA2777800C (en) 2009-10-15 2019-11-12 Crescendo Bioscience Biomarkers and methods for measuring and monitoring inflammatory disease activity
US10192641B2 (en) 2010-04-29 2019-01-29 The Regents Of The University Of California Method of generating a dynamic pathway map
JP6073217B2 (ja) 2010-04-29 2017-02-08 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ゲノムモデルに関するデータ統合を用いたパスウェイ認識アルゴリズム（ｐａｒａｄｉｇｍ）
WO2012066536A2 (en) * 2010-11-16 2012-05-24 Prediguard Transcriptome signatures discriminate etanercept-treated rheumatoid arthritis (ra) patients according to their response or refractory status
US20130040835A1 (en) * 2011-05-05 2013-02-14 Exagen Diagnostics, Inc Genes predictive of anti-TNF response in inflammatory diseases
CA3295783A1 (en) 2011-05-10 2026-03-02 Prometheus Laboratories, Inc. Methods of disease activity profiling for personalized therapy management
US9416190B2 (en) 2012-09-27 2016-08-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mesothelin antibodies and methods for eliciting potent antitumor activity
HU230680B1 (hu) * 2012-10-19 2017-08-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Diagnosztikai eljárás
DK2914739T3 (da) 2012-11-05 2017-11-27 Novigenix Sa Kombinationer af biomarkører for kolorektale tumorer
CA2892490A1 (en) 2012-11-26 2014-05-30 Caris Science, Inc. Biomarker compositions and methods
US10161936B2 (en) 2013-03-08 2018-12-25 University Of Leipzig Method and kit for cytokine analysis from a human whole blood sample
US9945870B2 (en) 2013-05-17 2018-04-17 The Board Of Trustees Of The Leland Stanford Junior University Methods for determining responsiveness to an anti-CD47 agent
WO2015006213A1 (en) 2013-07-08 2015-01-15 Northeastern University Methods for identifying complex disease subtypes
US9387246B2 (en) 2013-09-03 2016-07-12 L. Douglas Graham Treatment methods for rheumatoid arthritis
WO2015084461A2 (en) 2013-09-23 2015-06-11 Northeastern University System and methods for disease module detection
CA2943821A1 (en) 2014-04-02 2015-10-08 Crescendo Bioscience Biomarkers and methods for measuring and monitoring juvenile idiopathic arthritis activity
WO2015164406A1 (en) 2014-04-21 2015-10-29 University Of South Florida Salivary inflammatory biomarkers associated with glycemic control and oral health
MX2017004742A (es) 2014-10-20 2017-07-20 Nestec Sa Métodos para la predicción de niveles de farmacos anti-tnf alfa y formación de autoanticuerpos.
JP2018504584A (ja) 2014-12-02 2018-02-15 ネステク ソシエテ アノニム 過敏性腸疾患患者を治療するためのベドリズマブの投与計画を確立する方法
HK1257443A1 (zh) 2015-08-21 2019-10-18 The Children's Hospital Of Philadelphia 治疗具有dcr3或dcr3网络基因中的遗传变异的患者的自身免疫病症的方法
US10018637B2 (en) 2015-10-06 2018-07-10 Celgene International Ii Sarl Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast
ES2716900T3 (es) * 2015-11-06 2019-06-17 Promise Advanced Proteomics Un método para cuantificar anticuerpos anti-TNF
US20190080051A1 (en) 2015-11-11 2019-03-14 Northeastern University Methods And Systems For Profiling Personalized Biomarker Expression Perturbations
US20170145501A1 (en) * 2015-11-20 2017-05-25 Lasse Folkersen Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response
EP3440579A4 (en) * 2015-11-24 2020-03-25 Klaritos, Inc. INNOVATIVE MODEL OF DELIVERY, PROCESSING AND PAYMENT FOR SPECIALIZED MEDICINES
GB201521357D0 (en) * 2015-12-03 2016-01-20 Univ Liverpool Methods for predicting response to anti-TNF therapy
JP6572120B2 (ja) 2015-12-14 2019-09-04 浜松ホトニクス株式会社 光ビーム照射装置
WO2017151755A1 (en) * 2016-03-02 2017-09-08 Crescendo Bioscience Biomarkers and methods for predicting response to discontinuation of inflammatory disease therapy
WO2017223116A2 (en) 2016-06-20 2017-12-28 Healthtell Inc. Methods for differential diagnosis of autoimmune diseases
EP3654993A4 (en) 2017-07-17 2021-08-25 The Broad Institute, Inc. CELL ATLAS OF HEALTHY HUMAN COLUMN AND HUMAN COLUMN WITH COLITIS ULCEROSA
US20200165677A1 (en) 2017-07-18 2020-05-28 Thaddeus Stappenbeck Methods and uses of inflammatory bowel disease biomarkers
US20190287644A1 (en) 2018-02-15 2019-09-19 Northeastern University Correlation Method To Identify Relevant Genes For Personalized Treatment Of Complex Disease
WO2019178546A1 (en) 2018-03-16 2019-09-19 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
WO2020198068A1 (en) 2019-03-22 2020-10-01 Inflammatix, Inc. Systems and methods for deriving and optimizing classifiers from multiple datasets
SG11202110655UA (en) 2019-03-28 2021-10-28 Phase Genomics Inc Systems and methods for karyotyping by sequencing
JP2022541125A (ja) 2019-06-27 2022-09-22 サイファー メディシン コーポレーション 患者を層別化するための分類子の開発
WO2022051245A2 (en) 2020-09-01 2022-03-10 Scipher Medicine Corporation Methods and systems for predicting response to anti-tnf therapies
EP4308732A4 (en) 2021-03-19 2025-02-26 Scipher Medicine Corporation METHODS FOR CLASSIFICATION AND TREATMENT OF PATIENTS
WO2023150731A2 (en) 2022-02-04 2023-08-10 Scipher Medicine Corporation Systems and methods for predicting response to anti-tnf therapies

Similar Documents

Publication Publication Date Title
Czarnewski et al. Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification
US11456056B2 (en) Methods of treating a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier
US20240199729A1 (en) Methods and systems for predicting response to anti-tnf therapies
JP6931125B2 (ja) 標的遺伝子発現の数学的モデル化を使用する、ｊａｋ−ｓｔａｔ１／２細胞シグナル伝達経路活性の評価
JP2022541125A5 (enExample)
CN110168106B (zh) 预测进展期胃癌患者的术后预后或抗癌药物适合性的系统
JP2022101590A (ja) 炎症性病態の治療応答の予測
JP2023538963A5 (enExample)
AU2021336781A9 (en) Methods and systems for predicting response to anti-tnf therapies
JP2022048190A (ja) ドライアイ疾患の予後のための遺伝子シグネチャー
US20170145501A1 (en) Apparatus and methods of using of biomarkers for predicting tnf-inhibitor response
JP2023521168A (ja) 関節リウマチにおける疾患進行を予測する方法
US20250075258A1 (en) Methods of detecting sjogren's syndrome using salivary exosomes
WO2023061240A1 (zh) 免疫球蛋白A肾病RhoGTPase相关诊断标志物
WO2023061241A1 (zh) 免疫球蛋白a肾病t细胞诊断标志物
EP4203921A2 (en) Mrna biomarkers for diagnosis of liver disease
CN115772213B (zh) Notch3突变体及其应用
GB2547406A (en) Apparatus and methods of using of biomarkers for predicting TNF-inhibitor response
Eken et al. POS0675 DIFFERENCES IN THE CHARACTERISTICS OF D2T/NOND2T-RA PATIENTS AND FACTORS ASSOCIATED WITH D2T-RA AT B/TSDMARD START
Bai From Molecules to Medicine: Expanding the Therapeutic Streetlight for Inflammatory Bowel Diseases
WO2024077282A2 (en) Biomarkers for the diagnosis of amyotrophic lateral sclerosis
WO2025155886A1 (en) Methods for determining responsiveness to cancer therapy
WO2014080204A1 (en) Assay method
Variola et al. P220 IBIS-Q (IBd Identification of Spondyloarthrytis Questionnaire): a new tool to detect spondyloarthritis in inflammatory bowel diseases
McClean et al. Blood Transcriptomic and Clinical Biomarkers for Prediction of Tuberculosis Recurrence: A Multi-Country Validation Study​